These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15180141)

  • 1. Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone.
    Singal N; Hopkins J
    Can J Ophthalmol; 2004 Apr; 39(3):245-50. PubMed ID: 15180141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
    Heier JS; Topping TM; Baumann W; Dirks MS; Chern S
    Ophthalmology; 2000 Nov; 107(11):2034-8;discussion 2039. PubMed ID: 11054327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
    Wingert AM; Liu SH; Lin JC; Sridhar J
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD004239. PubMed ID: 36520144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
    Wittpenn JR; Silverstein S; Heier J; Kenyon KR; Hunkeler JD; Earl M;
    Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG; Lira RP; Zanetti FR; Machado MC; Rodrigues GB; Arieta CE
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):495-501. PubMed ID: 24735005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
    Ramakrishnan S; Baskaran P; Talwar B; Venkatesh R
    Asia Pac J Ophthalmol (Phila); 2015; 4(4):216-20. PubMed ID: 26225780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
    Almeida DR; Johnson D; Hollands H; Smallman D; Baxter S; Eng KT; Kratky V; ten Hove MW; Sharma S; El-Defrawy S
    J Cataract Refract Surg; 2008 Jan; 34(1):64-9. PubMed ID: 18165083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
    Rho DS
    J Cataract Refract Surg; 2003 Dec; 29(12):2378-84. PubMed ID: 14709300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
    Weisz JM; Bressler NM; Bressler SB; Schachat AP
    Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial.
    Erichsen JH; Holm LM; Forslund Jacobsen M; Forman JL; Kessel L
    JAMA Ophthalmol; 2021 Oct; 139(10):1062-1070. PubMed ID: 34383010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.
    Walter KA; Lee RY; Chen K; Komanski C
    Arq Bras Oftalmol; 2020; 83(1):55-61. PubMed ID: 31664337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C; Neubauer AS; Kampik A; Schönfeld CL
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery.
    Sivaprasad S; Bunce C; Crosby-Nwaobi R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD004239. PubMed ID: 22336801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
    Donnenfeld ED; Perry HD; Wittpenn JR; Solomon R; Nattis A; Chou T
    J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine.
    Flach AJ; Jampol LM; Weinberg D; Kraff MC; Yannuzzi LA; Campo RV; Neumann AC; Cupples HP; Lefler WH; Pulido JS
    Am J Ophthalmol; 1991 Nov; 112(5):514-9. PubMed ID: 1951587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery.
    Sivaprasad S; Bunce C; Patel N
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004239. PubMed ID: 15674935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery.
    Visco DM; Bedi R
    J Cataract Refract Surg; 2020 Jun; 46(6):867-872. PubMed ID: 32541407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.
    Flach AJ; Dolan BJ; Irvine AR
    Am J Ophthalmol; 1987 Apr; 103(4):479-86. PubMed ID: 3551617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intraocular ketorolac tromethamine for the treatment of chronic cystoid macular edema.
    Margalit E; Boysen JL; Zastrocky JP; Katz A
    Can J Ophthalmol; 2010 Aug; 45(4):409-10. PubMed ID: 20648080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.